Given that inflammation involves complex cross-talk and interaction into molecular and cellular mechanisms with all stages of tumor development, future studies with a prospective design are needed to achieve the understanding of associations between dietary antioxidant capacity, IL-6 level, and risk of CRC with comprehensive factors in the inflammatory tumor microenvironment. The gene discussed is IL6; the disease is neoplasm.